MedTrace Logo

Ethics Communication in Groups Among Healthcare Professionals (The Ethics-com Study).

NCT05146102 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-12-06

No results posted yet for this study

Summary

Moral distress has been described as a condition with frustration, guilt, anger and as one reason for health care professionals to leave the profession. Ethics communication in groups has been showed to work as support for health care professionals in ethically difficult situations and further work as a tool to improve the ethical climate and prevent moral distress. Our research group has developed the "one to five-step method" for interprofessional ethical communication in groups. The overall aim of this project: is to implement and evaluate a method for organized interprofessional communication about ethical issues in healthcare.

Conditions

  • Ethics Support

Interventions

OTHER

ethics communication in group, in line with "the one to five-step method"

Healthcare professionals working as "ethical representatives" at the current ward (n=5) have recently gone through a basic ethics program. They will continue by going through an education program for facilitating ethics communication in group, in line with "the one to five-step method" The education program has a theoretical and practical approach, which includes the theoretical base of the ethical communication in groups and practicing "the one to five method" Thereafter, each "ethical representative" will facilitate interprofessional sessions at a clinical ward, once a month, for six months at their workplace. Gathering meetings for feedback will be offered for the "ethical representatives" once a month.

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Margareta Brännström · Umea university, department of nursing, Umeå, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-05-15
Completion
2022-05-15

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05146102 on ClinicalTrials.gov